Brain Edema in Acute Liver Failure

Critical Care Clinics

Volumn 24, Issue 1, 2008, Pages 99-114

  Blei, Andres T ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AMMONIA; CORTICOSTEROID DERIVATIVE; MANNITOL; NUCLEOSIDE ANALOG; PARACETAMOL; PLACEBO; SODIUM CHLORIDE; STEROID;

ANTIBIOTIC PROPHYLAXIS; ASPERGILLOSIS; AUTOIMMUNE HEPATITIS; BLOOD CLOTTING DISORDER; BRAIN BLOOD FLOW; BRAIN DISEASE; BRAIN EDEMA; BRAIN HYPEREMIA; BRAIN WATER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG INTOXICATION; HEPATIC ENCEPHALOPATHY; HEPATITIS A; HEPATITIS B; HEPATITIS E; HUMAN; HYPEREMIA; HYPONATREMIA; HYPOTHERMIA; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; LIVER FAILURE; LIVER FUNCTION; LIVER REGENERATION; LIVER TRANSPLANTATION; MULTIPLE ORGAN FAILURE; NONHUMAN; OSMOTIC STRESS; OXIDATIVE STRESS; PATHOGENESIS; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

AMMONIA; BRAIN EDEMA; CRITICAL CARE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER FAILURE, ACUTE; PROGNOSIS;

EID: 38649113597     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2007.11.001     Document Type: Review

References (73)

1. Larson A.M., Polson J., Fontana R.M., et al. Acetaminophen-induced ALF: results of a United States multicenter, prospective study. Hepatology 42 (2005) 1364-1372
2. Makin A.J., Wendon J., and Williams R. A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993). Gastroenterology 109 (1995) 1907-1916
3. Schmidt L.E., Dalhoff K., and Poulsen H.E. Acute versus chronic alcohol consumption in acetaminophen-induced hepatotoxicity. Hepatology 35 (2002) 876-882
4. Davern II T.J., James L.P., Hinson J.A., et al. Measurement of serum acetaminophen-protein adducts in patients with ALF. Gastroenterology 130 (2006) 687-694
5. Garfein R.S., Bower W.A., Loney C.M., et al. Factors associated with ALF during an outbreak among injection drug users with acute hepatitis B. Hepatology 40 (2004) 865-873
6. O'Grady J.G., Schalm S.W., and Williams R. Acute liver failure: redefining the syndromes. Lancet 342 (1993) 273-275
7. Elinav E., Ben-Dov I., Hai-Am E., et al. The predictive value of admission and follow up factor V and VII levels in patients with acute hepatitis and coagulopathy. J Hepatol 42 (2005) 82-86
8. Bucuvalas J., Yazigi N., and Squires Jr. R.H. Acute liver failure in children. Clin Liver Dis 10 (2006) 149-168
9. Vaquero J., Polson J., Chung C., et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology 125 (2003) 755-764
10. Bernal W., Hall C., Karvellas C.J., et al. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology (2007 Aug 8) [Epub ahead of print]
11. Blei A.T. Selection for acute liver failure: have we got it right?. Liver Transpl 11 Suppl 2 (2005) S30-S34
12. Bernuau J., Goudeau A., Poynard T., et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 6 (1986) 648-651
13. Kremers W.K., van Ijperen M., Kim W.R., et al. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology 39 (2004) 764-779
14. Shawcross D., and Jalan R. The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation. Cell Mol Life Sci 62 (2005) 2295-2304
15. Rose C., Butterworth R.F., Zayed J., et al. Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology 117 (1999) 640-644
16. Felipo V., and Butterworth R. Neurobiology of ammonia. Prog Neurobiol 67 (2002) 259-279
17. Haussinger D., Blei A., et al. Hepatic encephalopathy. In: Rodes J., Benhamou J., and Blei A. (Eds). Textbook of hepatology (2007), Blackwell, Oxford (England) 728-760
18. Vaquero J., Chung C., Cahill M.E., et al. Pathogenesis of hepatic encephalopathy in acute liver failure. Semin Liver Dis 23 (2003) 259-269
19. Ranjan P., Mishra A.M., Kale R., et al. Cytotoxic edema is responsible for raised intracranial pressure in fulminant hepatic failure: in vivo demonstration using diffusion-weighted MRI in human subjects. Metab Brain Dis 20 (2005) 181-192
20. Donovan J.P., Schafer D.F., Shaw Jr. B.W., et al. Cerebral oedema and increased intracranial pressure in chronic liver disease. Lancet 351 (1998) 719-721
21. Haussinger D. Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology 43 (2006) 1187-1190
22. Enns G.M., Berry S.A., Berry G.T., et al. Survival after treatment with phenylacetate and benzoate for urea-cycle disorders. N Engl J Med 356 (2007) 2282-2292
23. Clemmesen J.O., Larsen F.S., Kondrup J., et al. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 29 (1999) 648-653
24. Bhatia V., Singh R., and Acharya S.K. Predictive value of arterial ammonia for complications and outcome in acute liver failure. Gut 55 (2006) 98-104 Epub 2005 Jul 15
25. Rolando N., Wade J., Davalos M., et al. The systemic inflammatory response syndrome in acute liver failure. Hepatology 32 (2000) 734-739
26. Wiest R., and Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology 41 (2005) 422-433
27. Córdoba J., Gottstein J., and Blei A.T. Chronic hyponatremia exacerbates ammonia-induced brain edema in rats after portacaval anastomosis. J Hepatol 29 (1998) 589-594
28. Frasier C.L., and Arieff A.L. Epidemiology, pathophysiology, and management of hyponatremic encephalopathy. Am J Med 102 (1997) 67-77
29. Martín-Llahí M., Guevara M., and Ginès P. Hyponatremia in cirrhosis: clinical features and management. Gastroenterol Clin Biol 30 (2006) 1144-1151
30. Blei A.T. The pathophysiology of brain edema in acute liver failure. Neurochem Int 47 (2005) 71-77
31. Swain M., Butterworth R.F., and Blei A.T. Ammonia and related amino acids in the pathogenesis of brain edema in acute ischemic liver failure in rats. Hepatology 15 (1992) 449-453
32. McConnell J.R., Antonson D.L., Ong C.S., et al. Proton spectroscopy of brain glutamine in acute liver failure. Hepatology 22 (1995) 69-74
33. Strange K. Cellular volume homeostasis. Adv Physiol Educ 28 (2004) 155-159
34. Sugimoto H., Koehler R.C., Wilson D.A., et al. Methionine sulfoximine, a glutamine synthetase inhibitor, attenuates increased extracellular potassium activity during acute hyperammonemia. J Cereb Blood Flow Metab 17 (1997) 44-49
35. Häussinger D., Laubenberger J., vom Dahl S., et al. Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. Gastroenterology 107 (1994) 1475-1480
36. Schliess F., Görg B., and Häussinger D. Pathogenetic interplay between osmotic and oxidative stress: the hepatic encephalopathy paradigm. Biol Chem 387 (2006) 1363-1370
37. Butterworth R.F. The astrocytic ("peripheral-type") benzodiazepine receptor: role in the pathogenesis of portal-systemic encephalopathy. Neurochem Int 36 (2000) 411-416
38. Norenberg M.D. Oxidative and nitrosative stress in ammonia neurotoxicity. Hepatology 37 (2003) 245-248
39. Warskulat U., Görg B., Bidmon H.J., et al. Ammonia-induced heme oxygenase-1 expression in cultured rat astrocytes and rat brain in vivo. Glia 40 (2002) 324-336
40. Vaquero J., Chung C., and Blei A.T. Cerebral blood flow in acute liver failure: a finding in search of a mechanism. Metab Brain Dis 19 (2004) 177-194
41. Jalan R., Olde Damink S.W., Deutz N.E., et al. Moderate hypothermia prevents cerebral hyperemia and increase in intracranial pressure in patients undergoing liver transplantation for acute liver failure. Transplantation 75 (2003) 2034-2039
42. Aggarwal S., Obrist W., Yonas H., et al. Cerebral hemodynamic and metabolic profiles in fulminant hepatic failure: relationship to outcome. Liver Transpl 11 (2005) 1353-1360
43. Ellis A.J., Wendon J.A., and Williams R. Subclinical seizure activity and prophylactic phenytoin in acute liver failure: a controlled clinical trial. Hepatology 32 (2000) 536-541
44. Bhatia V., Batra Y., and Acharya S.K. Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure-a controlled clinical trial. J Hepatol 41 (2004) 89-96
45. Stravitz T., Kramer A.H., Davern T., et al. Intensive care of patients with acute liver failure: recommendations of the U.S. acute liver failure study group. Crit Care Med 35 (2007) 2498-2508
46. Wijdicks E.F., Plevak D.J., Rakela J., et al. Clinical and radiologic features of cerebral edema in fulminant hepatic failure. Mayo Clin Proc 70 (1995) 119-124
47. Bernuau J., and Durand F. Intracranial pressure monitoring in patients with acute liver failure: a questionable invasive surveillance. Hepatology 44 (2006) 502-504
48. Wendon J.A., and Larsen F.S. Intracranial pressure monitoring in acute liver failure. A procedure with clear indications. Hepatology 44 (2006) 504-506
49. Blei A.T., Olafsson S., Webster S., et al. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet 341 (1993) 157-158
50. Vaquero J., Fontana R.J., Larson A.M., et al. Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl 11 (2005) 1581-1589
51. Shami V.M., Caldwell S.H., Hespenheide E.E., et al. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transpl 9 (2003) 138-143
52. Pavese P., Bonadona A., Beaubien J., et al. FVIIa corrects the coagulopathy of fulminant hepatic failure but may be associated with thrombosis: a report of four cases. Can J Anaesth 52 (2005) 26-29
53. O'Brien C.J., Wise R.J., O'Grady J.G., et al. Neurological sequelae in patients recovered from fulminant hepatic failure. Gut 28 (1987) 93-95
54. Kumar M., Satapathy S., Monga R., et al. A randomized controlled trial of lamivudine to treat acute hepatitis B. Hepatology 45 (2007) 97-101
55. Osawa M., Ito Y., Hirai T., et al. Risk factors for invasive aspergillosis in living donor liver transplant recipients. Liver Transpl 13 (2007) 566-570
56. Keays R., Harrison P.M., Wendon J.A., et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ 303 (1991) 1026-1029
57. Lee W.M., Rossaro L., Fontana R., et al. Intravenous N-acetylcysteine improves spontaneous survival in early stage non-acetaminophen acute liver failure. Hepatology 46 (2007) 71A
58. James L.P., Mayeux P.R., and Hinson J.A. Acetaminophen-induced hepatotoxicity. Drug Metab Dispos 31 (2003) 1499-1506
59. Wendon J.A., Harrison P.M., Keays R., et al. Cerebral blood flow and metabolism in fulminant liver failure. Hepatology 19 (1994) 1407-1413
60. Philips B.J., Armstrong I.R., Pollock A., et al. Cerebral blood flow and metabolism in patients with chronic liver disease undergoing orthotopic liver transplantation. Hepatology 27 (1998) 369-376
61. Zafarullah M., Li W.Q., Sylvester J., et al. Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci 60 (2003) 6-20
62. Mujais S., Blei A.T., and Cordoba J. Determinants of ammonia clearance by hemodialysis. Artif Organs 20 (1996) 800-803
63. Larsen F.S., and Wendon J. Brain edema in liver failure: basic physiologic principles and management. Liver Transpl 8 (2002) 983-989
64. Rolando N., Wade J.J., Stangou A., et al. Prospective study comparing the efficacy of prophylactic parenteral antimicrobials, with or without enteral decontamination, in patients with acute liver failure. Liver Transpl Surg 2 (1996) 8-13
65. Murphy N., Auzinger G., Bernel W., et al. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 39 (2004) 464-470
66. Tofteng F., and Larsen F.S. The effect of indomethacin on intracranial pressure, cerebral perfusion and extracellular lactate and glutamate concentrations in patients with fulminant hepatic failure. J Cereb Blood Flow Metab 24 (2004) 798-804
67. Demetriou A.A., Brown Jr. R.S., Busuttil R.W., et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 239 (2004) 660-667
68. Ben Abraham R., Szold O., Merhav H., et al. Rapid resolution of brain edema and improved cerebral perfusion pressure following the molecular adsorbent recycling system in acute liver failure patients. Transplant Proc 33 (2001) 2897-2899
69. Jalan R., Damink S.W., Deutz N.E., et al. Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet 354 (1999) 1164-1168
70. Jalan R., Olde Damink S.W., Deutz N.E., et al. Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. Gastroenterology 127 (2004) 1338-1346
71. Polderman K.H. Application of therapeutic hypothermia in the intensive care unit. Opportunities and pitfalls of a promising treatment modality-Part 1: indications and evidence. Intensive Care Med 30 (2004) 556-575
72. Vaquero J., and Blei A.T. Mild hypothermia for acute liver failure: a review of mechanisms of action. J Clin Gastroenterol 39 Suppl 2 (2005) S147-S157
73. Neuberger J. Prediction of survival for patients with fulminant hepatic failure. Hepatology 41 (2005) 19-22